214 related articles for article (PubMed ID: 21511531)
21. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
22. Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.
Chen H; Yong W; Hinds TD; Yang Z; Zhou Y; Sanchez ER; Shou W
J Biol Chem; 2010 Sep; 285(36):27776-84. PubMed ID: 20605780
[TBL] [Abstract][Full Text] [Related]
23. Impact of FKBP52 on cell proliferation and hormone-dependent cancers.
Hanaki S; Shimada M
Cancer Sci; 2023 Jul; 114(7):2729-2738. PubMed ID: 37026526
[TBL] [Abstract][Full Text] [Related]
24. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.
Riggs DL; Roberts PJ; Chirillo SC; Cheung-Flynn J; Prapapanich V; Ratajczak T; Gaber R; Picard D; Smith DF
EMBO J; 2003 Mar; 22(5):1158-67. PubMed ID: 12606580
[TBL] [Abstract][Full Text] [Related]
25. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
[TBL] [Abstract][Full Text] [Related]
26. FKBP52.
Davies TH; Sánchez ER
Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
[TBL] [Abstract][Full Text] [Related]
27. Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling.
Riggs DL; Cox MB; Tardif HL; Hessling M; Buchner J; Smith DF
Mol Cell Biol; 2007 Dec; 27(24):8658-69. PubMed ID: 17938211
[TBL] [Abstract][Full Text] [Related]
28. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
[TBL] [Abstract][Full Text] [Related]
29. Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.
Wolf IM; Periyasamy S; Hinds T; Yong W; Shou W; Sanchez ER
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):36-45. PubMed ID: 19073255
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.
Warrier M; Hinds TD; Ledford KJ; Cash HA; Patel PR; Bowman TA; Stechschulte LA; Yong W; Shou W; Najjar SM; Sanchez ER
Endocrinology; 2010 Jul; 151(7):3225-36. PubMed ID: 20427484
[TBL] [Abstract][Full Text] [Related]
31. FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
Stechschulte LA; Sanchez ER
Curr Opin Pharmacol; 2011 Aug; 11(4):332-7. PubMed ID: 21565552
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.
Galigniana MD; Radanyi C; Renoir JM; Housley PR; Pratt WB
J Biol Chem; 2001 May; 276(18):14884-9. PubMed ID: 11278753
[TBL] [Abstract][Full Text] [Related]
33. Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity.
Shi D; Bai Q; Zhou S; Liu X; Liu H; Yao X
Proteins; 2018 Jan; 86(1):43-56. PubMed ID: 29023988
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus.
Daikoku T; Tranguch S; Friedman DB; Das SK; Smith DF; Dey SK
Mol Endocrinol; 2005 Mar; 19(3):683-97. PubMed ID: 15528267
[TBL] [Abstract][Full Text] [Related]
35. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
[TBL] [Abstract][Full Text] [Related]
36. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.
Wu B; Li P; Liu Y; Lou Z; Ding Y; Shu C; Ye S; Bartlam M; Shen B; Rao Z
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8348-53. PubMed ID: 15159550
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52.
Miyata Y; Chambraud B; Radanyi C; Leclerc J; Lebeau MC; Renoir JM; Shirai R; Catelli MG; Yahara I; Baulieu EE
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14500-5. PubMed ID: 9405642
[TBL] [Abstract][Full Text] [Related]
38. Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin FKBP52.
Hirota Y; Burnum KE; Acar N; Rabinovich GA; Daikoku T; Dey SK
Endocrinology; 2012 May; 153(5):2486-93. PubMed ID: 22416080
[TBL] [Abstract][Full Text] [Related]
39. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
40. Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.
Mustafi SM; LeMaster DM; Hernández G
Biochem J; 2014 Jul; 461(1):115-23. PubMed ID: 24749623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
